Dmitry Karshtedt

Dmitry Karshtedt
Title:
Associate Professor of Law
Address:
2000 H Street, NW
Washington, District Of Columbia 20052
Phone:
202-994-5725
Email:
[email protected]

Dmitry Karshtedt's primary research interest is in patent law. His legal scholarship has been published in the Vanderbilt Law Review, Washington University Law Review, and Iowa Law Review, among other outlets, and cited in three of the leading patent law casebooks, a casebook on intellectual property, and three treatises. Professor Karshtedt's academic work has won several awards, including the Samsung-Stanford Patent Prize and the scholarship grant for judicial clerks sponsored by the University of Houston Law Center Institute for Intellectual Property and Information Law.

Before going into law, Professor Karshtedt completed a Ph.D. in chemistry from U.C. Berkeley and worked as a staff scientist for a semiconductor materials startup. He is a co-author on five scientific publications and a co-inventor on twelve U.S. patents. Professor Karshtedt received his law degree from Stanford Law School, where he served as the Senior Symposium Editor for the Stanford Law Review. Professor Karshtedt practiced in the Patent Counseling and Innovation Group at Wilson Sonsini Goodrich & Rosati and clerked for the Honorable Kimberly A. Moore on the U.S. Court of Appeals for the Federal Circuit. Immediately prior to starting his position at GW, Professor Karshtedt was a Fellow at the Center for Law and the Biosciences at Stanford Law School.

Curriculum Vitae     Publications

Education

AB, Harvard University; PhD, UC Berkeley; JD, Stanford University

In the News

"5 Questions From Tuesday's Cert Grant on PTO Judge Appointments"

October 13, 2020

Dmitry Karshtedt is quoted in The National Law Journal on what happens next after SCOTUS granted cert in USPTO appointments clause cases.

"Glaxo/Teva Ruling Could Spell Trouble for Generic Drug Makers"

October 05, 2020

Dmitry Karshtedt is quoted by Bloomberg Law about how a Federal Circuit decision could lead to changes for the generic drug industry.

"PTO's Real Parties Decision Casts Cloud Over Member-Supported Patent Challenges"

October 05, 2020

Dmitry Karshtedt is quoted in Law.com about whether member-supported organizations will be blocked from invoking the AIA in future cases.

"Pharma Giants Tee Up Biologics Innovation Fight At Fed. Circ."

August 21, 2020

Dmitry Karshtedt is quoted by Law360 about a Federal Circuit case that could impact how drugmakers can patent biologics.

"Sweat the Small Stuff: Lessons of Federal Circuit Damages Cases"

August 21, 2020

Dmitry Karshtedt is quoted by Bloomberg Law about takeaways from six recent Federal Circuit damages decisions.